Pre-ANDA product development and ANDA pre-submission meetings join Type A and Biosimilar Product Development Type 1 meetings as eligible for the hybrid format. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".